Alternatives to LifeMD

The brand-access marketplace: real FDA-approved pens and oral options with insurance-style navigation — but a required video visit, a 28-day billing cycle, and prices that sit well above the compounded field.

AskRx solves the pricing question most of this page leaves open, and creates a different one. Its care fee is itemized in its own footnote — $90/month physician visit, $10/month fulfilment, $100 total — and the medication is billed separately through its own pharmacy, at cost, with both halves shown at checkout. If you have ever wondered how much of a blended monthly price is the drug and how much is margin, this is the provider that answers it. It is FDA-approved only ('No compounded meds'), so the options are the Wegovy pen, the Wegovy pill, Zepbound in pen or KwikPen form, and Foundayo, the oral tirzepatide. All 50 states, board-certified physicians with obesity-medicine training, unlimited messaging, monthly titration, cancel anytime. Two logistics notes that matter on a workday. First, $100 is a floor: no medication price is published, so your real monthly total is unknown until checkout and depends on coverage. Second — and read this one if scheduling is your constraint — 'video visits available in select states' means the async route is not universal here, so confirm your own state before assuming you can do this without a call.

The sum is transparent and it is the seller's own: $99 a month for the service, plus the manufacturer's charge — $299 for the Zepbound starter pen, $149 for the Wegovy pill — giving $398 and $248. The first month is $25 instead of $99. Both of those manufacturer figures are LillyDirect's and NovoCare's own, so the arithmetic can be checked from outside, and it holds. What is not published is the ladder as your dose climbs.

A sublingual (under-the-tongue), not injectable, GLP-1 program — $189/mo semaglutide and $319/mo tirzepatide on a 6-month prepay plan, $209/mo and $359/mo on a shorter 2-month plan — serving 34 states plus DC.

The manufacturer's own channel for brand Wegovy — $149/mo self-pay or as low as $25/mo with commercial insurance — but it requires your own existing prescription and offers no tirzepatide, since that's a different company's drug.

An established longevity-telehealth brand with a microdose-first GLP-1 menu — starting at $99/mo microdosing semaglutide, $159/mo microdosing tirzepatide — plus brand-name Wegovy/Zepbound access-and-monitoring for a separate $50–$65 fee (drug cost billed apart).

The posted price is half the bill, and the site says so itself. Read live on 26 August 2026, the weight-loss catalog is ten FDA-approved brand listings — Wegovy as a pill and a pen, Zepbound as a vial and a KwikPen, Ozempic in both forms, Mounjaro, and two new oral tablets in the Ozempic Pill and Foundayo — and every single one carries the same footnote: the figure covers medication only, and a membership at $39 for the first month then $149 a month is required and billed separately. So the $149 Wegovy Pill is really about $298 a month and the $299 Zepbound vial is about $448. That membership is not nothing — 24/7 messaging with licensed providers, monthly care-team follow-ups, a smart scale and named in-house clinicians — but it is $1,788 a year on top of the drug. One oddity to open before you buy: Mounjaro and one of two Zepbound listings are posted at a flat $1,899 a month on the same page as Zepbound vials at $299, and nothing explains the gap. Its FAQ asks whether video visits are required and whether all states are served, but keeps both answers inside collapsed panels, so neither could be verified. It carries two FDA warning letters dated 9 September 2025 over the compounded-semaglutide business it has since left behind entirely.

A cardiometabolic telehealth platform built around diabetes care that also treats obesity — $149/mo self-pay or free with insurance, one price covering brand GLP-1s, labs, devices and a real multi-disciplinary care team, though it publishes no state list at all.

A major, highly recognizable brand — Amazon's own One Medical plus Amazon Pharmacy channel — offering FDA-approved Wegovy from $149/mo with a manufacturer coupon, plus the new oral Foundayo pill, though the $149 price depends on coupon eligibility.